Novonix (NVNXF) Form 6-K details ASX notice on offtake deal termination

Rhea-AI Filing Summary

Novonix Limited furnished a Form 6‑K for November 2025 to provide investors with an ASX announcement titled “Notice of Termination of Offtake Agreement” dated November 4, 2025. The report is signed on behalf of the company by Chief Financial Officer Robert Long.

Form 6-K: How Foreign Companies Report to the SEC →

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE

SECURITIES EXCHANGE ACT OF 1934

For the month of November, 2025

001-41208

(Commission File Number)

NOVONIX LIMITED

(Translation of registrant’s name into English)

Level 38

71 Eagle Street

Brisbane, QLD 4000 Australia

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20‑F or Form 40‑F.

Form 20-F ☒ Form 40-F ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐

EXHIBIT INDEX

Exhibit No.		Description
Exhibit 99.1		ASX Announcement (Notice of Termination of Offtake Agreement) dated November 4, 2025.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

NOVONIX LIMITED
By:		/s/ Robert Long
		Robert Long
		Chief Financial Officer

Date: November 4, 2025

FAQ

What did Novonix (NVNXF) report in this Form 6-K filing?

Novonix reported a Form 6-K furnishing an ASX announcement titled “Notice of Termination of Offtake Agreement”. The filing serves to make this overseas market announcement available to U.S. investors under the Securities Exchange Act of 1934.

What key document is attached to Novonix (NVNXF) Form 6-K?

The key document attached is Exhibit 99.1, described as an ASX Announcement titled “Notice of Termination of Offtake Agreement” dated November 4, 2025. This exhibit contains the detailed information referenced by the Form 6-K cover.

Who signed the November 2025 Form 6-K for Novonix (NVNXF)?

The Form 6-K was signed on behalf of Novonix Limited by Robert Long, the company’s Chief Financial Officer. His electronic signature appears in the filing, indicating the company’s authorization of the submitted report and accompanying exhibit.

When was the exhibit in Novonix (NVNXF) Form 6-K dated?

The attached ASX announcement in Exhibit 99.1 is dated November 4, 2025. This date reflects when the “Notice of Termination of Offtake Agreement” announcement was issued on the Australian Securities Exchange and then furnished to U.S. markets.

What type of issuer is Novonix (NVNXF) in this Form 6-K?

Novonix is treated as a foreign private issuer and uses Form 6-K to furnish information released in its home market. The filing notes that the company files or will file annual reports under cover of Form 20-F, consistent with this status.